Search details
1.
Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis.
Hepatology
; 77(1): 65-76, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-35491432
2.
Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study.
Chin J Cancer Res
; 36(1): 78-89, 2024 Feb 29.
Article
in English
| MEDLINE | ID: mdl-38455365
3.
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
Lancet Oncol
; 24(10): 1134-1146, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37797632
4.
Phase I study of MSB2311, a novel pH-dependent anti-PD-L1 monoclonal antibody, treating patients with advanced solid tumors and lymphoma.
Cancer Immunol Immunother
; 72(8): 2729-2739, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37115210
5.
P-element-Induced Wimpy-Testis-Like Protein 1 Regulates the Activation of Pancreatic Stellate Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Dig Dis Sci
; 68(4): 1339-1350, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36002675
6.
Phase Ia/Ib Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: Safety, Efficacy, and Biomarkers.
Oncologist
; 2022 Apr 21.
Article
in English
| MEDLINE | ID: mdl-35445725
7.
Safety, antitumor activity and biomarkers of sugemalimab in Chinese patients with advanced solid tumors or lymphomas: results from the first-in-human phase 1 trial.
Cancer Immunol Immunother
; 71(8): 1897-1908, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-34984540
8.
PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients.
Cancer Immunol Immunother
; 71(1): 111-120, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34028566
9.
Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.
BMC Med
; 20(1): 223, 2022 07 11.
Article
in English
| MEDLINE | ID: mdl-35811317
10.
Impact of 68Ga-NOTA-MAL-MZHER2 PET imaging in advanced gastric cancer patients and therapeutic response monitoring.
Eur J Nucl Med Mol Imaging
; 48(1): 161-175, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32564171
11.
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors.
Gastric Cancer
; 24(4): 913-925, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33945049
12.
A validated HPLC-MS/MS method for determination of simmitecan and its metabolite chimmitecan in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumor.
J Sep Sci
; 44(21): 3959-3966, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34472219
13.
Baseline derived neutrophil-to-lymphocyte ratio as a prognostic biomarker for non-colorectal gastrointestinal cancer patients treated with immune checkpoint blockade.
Clin Immunol
; 212: 108345, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31953149
14.
Use of Radiomics to Predict Response to Immunotherapy of Malignant Tumors of the Digestive System.
Med Sci Monit
; 26: e924671, 2020 Oct 20.
Article
in English
| MEDLINE | ID: mdl-33077705
15.
Hyperprogression after immunotherapy in patients with malignant tumors of digestive system.
BMC Cancer
; 19(1): 705, 2019 Jul 17.
Article
in English
| MEDLINE | ID: mdl-31315610
16.
Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features.
Gastric Cancer
; 22(6): 1183-1192, 2019 11.
Article
in English
| MEDLINE | ID: mdl-30989433
17.
Correction: Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.
BMC Med
; 21(1): 369, 2023 Sep 29.
Article
in English
| MEDLINE | ID: mdl-37775728
18.
MRI in predicting the response of gastrointestinal stromal tumor to targeted therapy: a patient-based multi-parameter study.
BMC Cancer
; 18(1): 811, 2018 Aug 13.
Article
in English
| MEDLINE | ID: mdl-30103713
19.
Clinical study of ultrasound and microbubbles for enhancing chemotherapeutic sensitivity of malignant tumors in digestive system.
Chin J Cancer Res
; 30(5): 553-563, 2018 Oct.
Article
in English
| MEDLINE | ID: mdl-30510367
20.
Clinical benefit of sunitinib in gastrointestinal stromal tumors with different exon 11 mutation genotypes.
Future Oncol
; 13(23): 2035-2043, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28685593